The European Chemicals Agency (ECHA) is consulting on potential candidates for substitution and on derogation conditions
The EU Biocidal Products Regulation 528/2012 (EU BPR) applies in NI.
If an active substance meets the exclusion criteria set out in Article 5 (1), it would not normally be approved for use in biocidal products. 2,2-dibromo-2-cyanoacetamide (DBNPA) has been identified as fulfilling at least one of the criteria set out in the Article 5 (1) exclusion criteria under EU BPR. Where an active substance meets at least one of the exclusion criteria listed in Article 5 (1), it may still be approved in accordance with Article 5 (2) if one of the following conditions are met: the risk to humans, animals or the environment from exposure to the active substance in a biocidal product, under realistic conditions of use, is negligible the active substance is essential to prevent a serious danger to human or animal health or the environment not approving the substance would have a disproportionate negative impact on society compared to the risks
In these circumstances the active substance will also be considered as a candidate for substitution under Article 10 (1) of the EU BPR.
Before submitting its opinion on the approval or renewal of the active substance to the Commission, ECHA will launch a consultation to collect information on potential alternatives to this substance (Article 10 (3) of EU BPR). The following active substance has been identified as a potential candidate for substitution under EU BPR and ECHA has launched a public consultation running until the stated date: 2,2-dibromo-2-cyanoacetamide (DBNPA) (CAS 233-539-7 EC 10222-01-2) in product type 12
17 November 2024
Comments should be submitted to ECHA using the dedicated webforms.
Please note this consultation and its outcome are not applicable under the GB Biocidal Products Regulations (GB BPR). | 